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Expression of the SV40 large T-antigen allows primary cells to escape senescence and thereby become immortalized.
Immortalization occurs in two steps, extension of life span and acquisition of unlimited cell division potential. By following the
increase in expression of a senescence-associated marker with increased cell passage, we show that C57Bl/6 mouse
embryo fibroblast (B6MEF) cultures senesce by passage 4. Thus, the development of colonies from cultures transfected with
T-antigen expressing constructs indicates extension of life span. Two T-antigen regions independently extended the life span
of B6MEF. Expression of either a T-antigen consisting of amino acids 1–147 (T1-147) or a T-antigen consisting of amino acids
251–708 (T251-708) resulted in colony development. However, the colonies expressing these truncated T-antigens could not
be expanded into cell lines efficiently. In contrast, coexpression of T1-147 and T251-708 produced colonies that could be
expanded into cell lines as efficiently as could colonies expressing full-length T-antigen. Thus, the two regions of T-antigen
contain analogous activities that are sufficient to extend cell life span; they cooperate to immortalize primary B6MEF; and
they act in trans, indicating that the functions involved are independent. © 1998 Academic Press
INTRODUCTION
Primary cells in culture divide a defined number of
times before reaching senescence (Hayflick and Moor-
head, 1961). The number of divisions that precede se-
nescence depends on the species of animal and tissue
from which the cells are derived. A number of viral and
activated cellular oncogenes produce products that al-
low cells to bypass senescence signals and thereby to
divide indefinitely. Expression of the simian virus 40
(SV40) large T-antigen is sufficient for primary cells to
escape senescence (reviewed in Manfredi and Prives,
1994; Ozer et al., 1996).
We previously used C57BL/6 mouse embryo fibroblast
cultures (B6MEF) to investigate regions of T-antigen in-
volved in escape from senescence (Tevethia, 1984; Te-
vethia et al., 1988, 1997a; Thompson et al., 1990, Kier-
stead and Tevethia, 1993). When these cells are seeded
into flasks at low density they stop dividing before suffi-
cient cells accumulate to form a cell monolayer. Primary
B6MEF that have integrated the large T-antigen coding
sequence and express the protein continue to divide and
form colonies. No colonies develop in the absence of
T-antigen expression. When the colonies are individually
removed from flasks, they are readily expanded into cell
lines, indicating that they are immortalized.
By using an extensive panel of N-terminal and internal
in-frame deletion mutants, we (Kierstead and Tevethia,
1993; Thompson et al., 1990) and others (Conzen and
Cole, 1995; Zhu et al., 1991) showed that the capacity of
T-antigens to promote escape from senescence in
B6MEF correlates directly with their ability to bind the
tumor supressor gene product p53. Removal of T-antigen
amino acids 1–127, 127–250, 251–300, 301–350, 400, or
451–532 did not compromise p53 binding or immortal-
ization. However, in general, removal of amino acids in
segments 351–450 or 533–626 inhibited both of these
activities.
In a recent study, Conzen and Cole (1995) investigated
further the relationships among specific mutations in
T-antigen and the ability to promote colony formation and
immortalization of B6MEF. The results confirmed that
cells transfected with plasmids encoding T-antigens with
altered p53-binding regions rarely formed colonies. In
contrast, cells expressing a T-antigen missing a portion
of the Rb-protein family binding site or a mutant missing
amino acids 5–35 from the region shared by large T- and
small t-antigens (T/t common region) formed colonies;
however, the colonies could not be expanded into con-
tinuous cell lines. Those results suggested that the N-
terminal activities were not needed in order to promote
colony formation, but they were essential for immortal-
ization. Additionally, the results suggested that binding
the tumor suppressor p53 was essential for both pro-
cesses. One would expect, therefore, that a segment of
T-antigen that binds p53 might be sufficient to extend cell
life span, whereas a segment that did not possess that
capacity would not.
In order to define the T-antigen regions that are suffi-1 To whom reprint requests should be addressed. Fax: (717)531-6522.
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cient to permit the generation of colonies from trans-
fected B6MEF and those that participate in immortalizing
cells, we examined the ability of an N-terminal fragment
of large T-antigen (T1-147) and a fragment that contains
the regions required for p53 binding (T251-708) to extend
the life span of B6MEF and to immortalize them. We
show here that either T-antigen segment will extend the
life span of primary cells; however, neither will indepen-
dently promote efficient escape from senescence. When
the two T-antigen segments are coexpressed, immortal-
ization occurs. We conclude that extension of cell life
span does not require p53 binding and that one or more
activities located within the N-terminal 147 amino acids
of T-antigen cooperate in trans with one or more activi-
ties located between amino acids 251 and 708 to allow
primary B6MEF to escape from senescence.
RESULTS
Entry of B6MEF into senescence
Primary C57BL/6 cells can be passaged few times in
culture before the cells fail to divide further. We (Tevethia,
1984; Tevethia et al., 1988, 1997a; Thompson et al., 1990,
Kierstead and Tevethia, 1993) and others (Chen and
Paucha, 1990; Conzen and Cole, 1995; Zhu et al., 1991)
have concluded, based on their failure to divide at sub-
confluent cell density and alterations in cell morphology,
that the cells became senescent. In order to gain infor-
mation as to the relative number of cells entering senes-
cence with increasing passage and to confirm that fail-
ure to divide at subconfluent density was directly related
to senescence, we followed expression of the endoge-
nous senescence-associated b-galactosidase (SA-b-gal)
(Dimri et al., 1995; Serrano et al., 1997) with increased
passage. Figure 2 and Table 1 show the results. Both the
percentage of cells expressing the senescence marker
and the intensity of staining increased steadily with pas-
sage (Table 1). By passage 4, 90% of the cells scored
positive for SA-b-gal. Therefore, on average, in order for
cells transfected with wild-type or mutant T-antigen to
form a colony composed of more than 32 cells, the
natural life span of the cell must be extended.
Colony formation in response to wild-type and mutant
T-antigens. Table 2 shows the results obtained when
B6MEF were transfected with plasmids that encode wild-
type large T- and small t-antigens (pPVU0), large T-anti-
gen only (pdl2005), a truncated T-antigen containing
amino acids 1–147 (T1-147), or a truncated T-antigen
containing amino acids 251–708 (T251-708). The experi-
ment was performed under two conditions. We showed
previously (Thompson et al., 1990) that removal of the
first 127 amino acids from T-antigen prevented cells
expressing the truncated T-antigen from growing to high
cell density, a property closely associated with loss of
contact inhibition of cell division. To rule out the possi-
bility that senescent cells remaining in the flasks im-
peded the growth of colonies expressing T1-147, T251-
708, or both, the experiments were performed both with
(experiment 1, Table 2) or without (experiment 2, Table 2)
removal of the residual nontransfected cells by selection
for expression of the dominant selectable gene confer-
ring G418 resistance.
The results were similar in both instances. In each
experiment, colonies appeared in flasks of cells that
received plasmids encoding both T1-708 and small t-
antigens or T1-708 only, T1-147, or T251-708. There was
no obvious difference in the range of sizes that colonies
attained in flasks that received wild-type T-antigen con-
structs and those that received mutant T-antigen con-
structs (data not shown). However, in general, colonies
TABLE 1
Increase in the Number of Cells Expressing a Senescence
Marker with Passage
Passage
no.a
Total number of
cells counted
Percentage expressing
SA-b-galb
2 374 3.3
3 235 45
4 240 90
5 297 84
a B6MEF were passaged 1:2 each time the monolayers became
confluent.
b SA-b-gal is the senescence-associated b-galactosidase activity
optimally active at pH 6.0.
TABLE 2
Formation of Colonies by B6MEF Transfected with Full-Length or
Truncated Large T-Antigensa
DNA T antigensb
Colonies per flask
Experiment 1c Experiment 2
pPVU0 T1-708, t 77,120 104,180
dl2005 T1-708 64, 85 79, 80
T147sacdl T1-147 42, 9 11, 18
CAV251-708 T251-708 27, 40 27, 30
T147sacdl
1 CAV251-708
T1-147,
T251-708
28, 30 23, 29
T147sacdl
1 CAV251-708
1 dl536
T1-147,
T251-708, t
73, 84 22, 30
Carrier None 5, 10 0, 5
a 75-cm2 flasks each containing 4 3 105 B6MEF were transfected
with 10 mg carrier DNA and 1 mg of wild-type or mutant T-antigen-
expressing plasmid. The following day and twice weekly thereafter the
medium was replaced with fresh DMEM–10% FBS. Colonies were
counted 3–4 weeks following transfection.
b Large T-antigens were named according to the amino acids they
contain. t, small t antigen.
c In experiment 1 each flask received in addition to the other DNAs
1 mg pSV2neo. Ten days later the medium was changed to DMEM–10%
FBS containing 500 mg G418/ml for all other medium changes.
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in flasks that received full-length T-antigen constructs
developed somewhat more rapidly. The number of colo-
nies that developed in flasks that received the truncated
T-antigen expression plasmids was somewhat lower (ap-
proximately 20–60%) than that in flasks that received
full-length T-antigen. We speculate that, given the rapidity
with which B6MEF cultures enter senescence, even
small reductions in the activity of T-antigen would be
reflected in modest reductions in colony formation. Sim-
ilarly, the numbers of colonies that developed in flasks of
cells transfected with the mutant T-antigen constructs
were more variable from experiment to experiment (Ta-
ble 2 and data not shown) than were the numbers of
colonies in flasks of cells transfected with wild-type T-
antigen constructs. These differences could reflect the
plating efficiency of cells in individual vials recovered
from storage in liquid nitrogen. The cell populations
recovered from liquid nitrogen are allowed to establish a
confluent monolayer prior to their use in immortalization
assays. It is possible that in individual experiments, the
MEF populations differ somewhat in the number of cells
approaching senescence at the time of transfection.
Such differences could lead to variability in the numbers
of colonies that develop. As expected, few or no colonies
developed in flasks that were transfected with carrier
DNA only. The development of a number of colonies that
was clearly and reproducibly higher than that in cultures
which received carrier DNA was taken as evidence that
the life span of the transfected cells was extended be-
yond the normal point of senescence.
Cotransfection of plasmids encoding T1-147 and T251-
708 or T1-147, T251-708, and small t-antigen did not
increase the number of colonies that developed. Thus,
expression of either of the two large T-antigen segments
was sufficient to extend the number of divisions that the
cells could sustain.
Immortalization of B6MEF by cooperating T-antigen
fragments. Three additional stages of cell division ca-
pacity beyond the development of colonies (described in
Fig. 1) were monitored. As shown in Table 3, all of
TABLE 3
Immortalization by Complementing T-Antigen Segments
DNA T-antigens
Expansion stagea
Experiment 1 (stage) Experiment 2 (stage)
1 2 3 1 2 3
pPVU0 T1-708, t ND ND ND 20/20 20/20 20/20
dl2005b T1-708 ND ND ND 20/20 20/20 20/20
T147sacdl T1-147 6/19 3/19 3/19 0/9 0/9 0/9
CAV251-708 T251-708 15/19 6/20 6/20 7/20 3/20 2/20
T147sacdl 1 CAV251-708 T1-147 1 T251-708 20/20 19/20 19/20 20/20 20/20 20/20
CAV251-708NL T251-708NL ND ND ND 1/11 0/11 0/11
T147sacdl 1 CAV251-708NL T1-147 1 T251-708NL ND ND ND 19/20 14/20 14/20
Note. ND, not done.
a Stage 1, confluent monolayer in 4.5-cm2 well. Stage 2, confluent monolayer in 25-cm2 flask. Stage 3, immortal cell line.
b Colonies that developed from cells transfected with wild-type T-antigen encoding constructs consistently all can be expanded into immortal cell
lines. Therefore, they are not consistently examined for that property.
FIG. 1. Stages in the process of immortalizing primary B6MEF.
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colonies tested that had developed after transfection of
plasmids encoding both T1-708 and small t-antigens or
T-708 alone could be expanded into cell lines. We
(Thompson et al., 1990) and others (Conzen and Cole,
1995) have shown consistently that small t-antigen does
not influence immortalization of B6MEF when the cells
are actively growing at the time of transfection and are
continually supplied with growth factors by frequent
changes of medium containing 10% FBS.
Only rarely could colonies that developed after trans-
fecting T1-147- or T251-708-expression plasmids be ex-
panded into cell lines. We conclude that although T-
antigens containing either the first 147 amino acids or
amino acids 251–708 are sufficient to extend cell line
span, neither is capable of independently immortalizing
primary B6MEF.
Large T-antigen is a nuclear protein. T1-147 also ac-
cumulates in the cell nucleus (Sompayrac and Danna,
1989). The T251-708 protein, however, does not contain a
nuclear localization signal and is expected to accumu-
late in the cell cytoplasm. Since large T-antigens with
genetic alterations in the nuclear localization signal im-
mortalize B6MEF (Thompson et al., 1990, and references
therein), it seemed unlikely that the inability of T251-708
to accumulate in the nucleus would account for its in-
ability to immortalize B6MEF. Nonetheless, it remained
formally possible that the T251-708 segment contained
independent immortalizing function that, when isolated
from the remainder of large T-antigen, was active only if
the truncated protein were in the nucleus. To rule out that
possibility we utilized a plasmid encoding a T251-708
protein to which the SV40 large T-antigen nuclear local-
ization signal was added immediately before amino acid
251 (T251-708NL) (Cavender et al., 1995). Figure 3 doc-
uments the cytoplasmic localization of T251-708 and the
nuclear localization of T251-708NL in transiently trans-
fected cells. The results in Table 2 show that colonies
that developed when B6MEF were transfected with the
construct encoding T251-708NL could not be expanded
into cell lines.
In contrast to colonies that developed from cells trans-
fected with plasmids encoding T1-147, T251-708, or T251-
FIG. 2. Increased expression of the senescence-associated b-galactosidase (SA-b-gal) by B6MEF with increased passage. At each passage cells
were seeded into dishes and stained 48 h later for SA-b-gal as described under Materials and Methods. A, passage 2; B, passage 3; C, passage 4;
D, passage 5.
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708NL alone, colonies in cultures that were cotrans-
fected with T1-147 and T251-708 or T1-147 and T251-
708NL constructs consistently were expanded into cell
lines.
Proteins expressed in cells immortalized by T1-147
plus T251-708
An immortal cell line (B6/T1-147 1 T251-708) derived
from colonies that developed in flasks of cells cotrans-
fected with T1-147- and T251-708-encoding constructs
were examined for the presence of the individual T-
antigen segments. To do so proteins were immunopre-
cipitated from extracts of [35S]methonine-labeled cells by
use of an irrelevant antibody (gD) or antibodies that
recognize an epitope in the T/t common region (PAb902),
the N-terminal unique large T region (PAb416), or the
C-terminus of large T-antigen (PAb901) and examined by
SDS–10%PAGE. As a control, proteins in an extract of
cells (B6/pPVU0) expressing wild-type large T- and small
t-antigen were treated similarly. The results appear in
Fig. 4. As expected, a protein with the apparent molec-
ular weight expected for large T-antigen appeared in the
lanes that received PAb902, PAb416, or PAb901 immuno-
precipitates of B6/pPVU0 extracts. Small t-antigen was
present in the PAb902 immunoprecipitate only. No pro-
teins were immunoprecipitated by the gD antibody. Two
proteins were immunoprecipitated from the labeled ex-
tracts of the coimmortalized cells. One of these was
immunoprecipitated by PAb901 only and migrated in the
gel as expected for the T251-708 protein. The second
was immunoprecipitated by PAb902 and PAb416, but not
by PAb901, indicating that it contained the epitope within
the T/t common region and between amino acids 83 and
127. The protein migrated as expected for the T1-147
protein. No protein in the position expected for full-length
T-antigen was observed at this or longer exposures (not
FIG. 3. The effect of adding an SV40 nuclear localization signal to T251-708. TC7 cells were transfected with the plasmid CAV251-708 (A) or
CAV251-708NL (B) and stained for T-antigen accumulation as described under Materials and Methods. In cultures transfected with CAV251-708 all
cells that accumulated T-antigen showed cytoplasmic fluorescence. In cultures transfected with CAV251-708NL all cells that accumulated T-antigen
showed nuclear fluorescence. A representative cell in each culture is shown.
FIG. 4. Immunoprecipitation of T-antigens from cells coimmortalized
by T1-147 and T251-708. Radiolabeled proteins were immunoprecipi-
tated from extracts of cells immortalized by wild-type large T-antigen
(B6/pPVU0) or coimmortalized by T1-147 and T251-708 (B6/T1-
1471T251-708) by the monoclonal antibodies indicated at the top of the
figure. The immunoprecipitated proteins were separated by SDS–PAGE
and detected by autoradiography.
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shown) of film to the gel. Three additional clonally de-
rived B6/T1-147 1 T251-708 cell lines were examined
similarly with the same results (not shown). Therefore,
the expansion of cells with extended life span into con-
tinuous cell lines depended on complementation be-
tween activities in separate and independent regions of
T-antigen and not on reconstitution of a protein contain-
ing the activities in cis. As expected cellular p53 was
coimmunoprecipitated with wild-type T-antigen and with
T251-708.
DISCUSSION
Primary cells in culture have a limited capacity for cell
division. Cell senescence represents its endpoint. In-
creasing evidence suggests that induction of the senes-
cence pathway is an effective deterrent to tumor forma-
tion (Serrano et al., 1997; Sugrue et al., 1997). Expression
of the SV40 large T-antigen is sufficient to allow primary
mouse cells to escape senescence. In B6MEF (Conzen
and Cole, 1995; Kierstead and Tevethia, 1993), as is true
in human cells (see Ozer et al., 1996, for review), the
alteration of the normal senescence program involves
two distinct and genetically dissociable stages, the ex-
tension of the normal cell life span, as defined by the
ability to exceed the number of cell divisions character-
istic of the normal cell, and immortalization, as defined
by acquisition of indefinite life span. Loss of function
analysis of the T-antigen functions involved in immortal-
ization has consistently implicated p53 binding in both
processes (Conzen and Cole, 1995; Kierstead and Te-
vethia, 1993; Zhu et al., 1991). The present study was
designed to determine the regions of T-antigen that were
sufficient for extension of cell life span and immortaliza-
tion. The results provide evidence for three conclusions.
First, the N-terminal T-antigen fragment T1-147 and the
fragment T251-708 independently extend the life span of
B6MEF. Second, the T1-147 and the T251-708 regions
together contain all of the activities needed to immortal-
ize cells. Amino acids 148 to 250 are not required. Third,
the two segments of T-antigen cooperate in trans to
immortalize cells.
The observation that T1-147 was sufficient to extend
the life span of B6MEF was contrary to predictions based
on loss-of-function genetic analyses of T-antigen. We
(Kierstead and Tevethia, 1993) and others (Conzen and
Cole, 1995; Zhu et al., 1991) showed previously that
transfection of B6MEF with mutant T-antigens containing
small internal in-frame deletions or insertions in the
p53-binding region rarely gave rise to colonies. The ex-
pectation from those results was that an N-terminal seg-
ment of T-antigen that did not include the p53-binding
region would not extend the life span of transfected cells.
The finding that T1-147 extended cell life span suggests
that distortion in the p53-binding region of the mutants
examined previously affects one or more immortaliza-
tion-related activities in the N-terminal 147 amino acids
on the same T-antigen molecule, whereas dissociation of
the N-terminal region from the p53-binding region does
not. A potentially similar circumstance has been reported
previously. Dickmanns et al. (1995) showed that the mu-
tation L19F/P28S in the context of full-length T-antigen
diminished its capacity to stimulate cellular DNA synthe-
sis, whereas the same mutation in an N-terminal T-
antigen fragment (T1-259) did not.
Conzen and Cole (1995) showed further that, whereas
alteration of the p53-binding region compromised forma-
tion of colonies by transfected B6MEF, removal of amino
acids 105–113, which constitute part of the binding site
for the Rb family of proteins, or amino acids 5–35 from
large T-antigen did not. A prediction, from those results,
was that a fragment of T-antigen that could bind and
inactivate p53 might be sufficient to extend cell life span.
We showed previously that the T251-708 protein binds
and inactivates p53 (Cavender et al., 1995). The results
presented here show that T251-708 is sufficient to extend
the life span of B6MEF. Whether an activity or activities
that reside within that segment are required in addition
to p53 binding remains to be determined.
Each of the segments that extends cell life span con-
tains activities related to progression of the cell cycle.
The T1-147 protein contains the binding site (LXCXE) for
the Rb family of proteins, Rb/p107/p130 (DeCaprio et al.,
1988; Dyson et al., 1990, 1989; Ewen et al., 1989). Binding
the Rb-family proteins is directly tied to the G1-S transi-
tion (reviewed in Ludlow and Skuse, 1995). Recently
(Porras et al., 1996) the conserved hexapeptide region
(Pipas, 1992) (amino acids 42–47) contained within the
DNA J domain (Srinivasin et al., 1997; Stubdal et al., 1997)
of T-antigen was shown to be essential to T-antigen’s
ability to transactivate the cyclin A promoter. Increases in
cyclin A are involved in the maintenance of S phase and
in the G2-M transition (Pagano et al., 1992). In addition
the LXCXE and the T/t common region together affect the
phosphorylation of p130 and p107 (Stubdal et al., 1996),
and the hexapeptide (DNA J) region is involved in the
rapid degradation of the hyperphosphorylated forms of
p130 (Stubdal et al., 1997). Both p130 and p107 have been
shown to have antiproliferative activities (Claudio et al.,
1994; Zhu et al., 1993).
Similarly, the T251-708 region contains activities re-
lated to cell cycle progression. This segment binds and
inactivates multiple functions of the tumor suppressor
protein p53 (reviewed in Manfredi and Prives, 1994) and
binds the cellular transcriptional coactivator protein
p300/CPB (Lill et al., 1997a,b; Eckner et al., 1996a). Both
proteins are negative regulators of cell growth (for re-
views see Ko and Prives, 1996; Levine, 1997; Bayley and
Mymryk, 1994; Eckner et al., 1996b; Puri et al., 1997) that
act cooperatively. The p300/CBP family members modu-
late the p53 functions involved in the cell cycle G1 check-
point and apoptosis induction (Lill et al., 1997a) and
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transcriptional stimulation as well as repression of p53-
regulated promoters (Gu et al., 1997; Lill et al., 1997a;
Avantaggiati et al., 1997; Scolnick et al., 1997; Sang et al.,
1997), and binding of p53 and p300 by viral oncoproteins
has been associated with stimulation of cell DNA syn-
thesis (Dickmanns et al., 1995; Dobbelstein et al., 1991;
Bayley and Mymryk, 1994). The precise relationships
among these activities in the two segments of T-antigen
and extension of life span and immortalization remain to
be determined.
The results presented here confirm the observation
(Kierstead and Tevethia, 1993) that whereas T1-147 is
sufficient to immortalize some rodent cell types (Som-
payrac and Danna, 1991), it is not sufficient to immortal-
ize B6MEF. As shown in Fig. 2, B6MEF cells enter se-
nescence at early passage. These cells were chosen for
immortalization studies specifically because of that prop-
erty. We reasoned that the few generations would de-
crease the likelihood that mutations in cellular genes
would contribute to the immortalization process. Since
activities of T-antigen extend the normal life span of
these cells, it remained possible that cellular mutations
could occur during the extended period. However, the
low number of colonies expressing the T1-147 fragment
alone that could be expanded into cell lines suggests
that in this system the life span extension afforded by
T1-147 is not sufficient to readily permit the accumulation
of mutations in cellular immortalizing genes. The same
conclusion can be applied to the T251-708 protein.
Activities from both the T1-147 and the T251-708 T-
antigen segments are required for immortalization. We
showed previously that removal of amino acids 127–250
from T-antigen did not abrogate immortalizing capacity
(Thompson et al., 1990). The current finding that T1-147
and T251-708 independently provide activities required
for escape from senescence extends that finding by
showing that potential conformationally determined ac-
tivities or protein modifications dependent on physical
interaction between the T-antigen N-terminus and the
C-terminus in cis (Scheidtmann et al., 1991) are not
needed. The ability of the cooperating immortalizing ac-
tivities to act in trans stands in contrast to the require-
ments for transforming the continuous cell lines REF52
and C3H10T1/2 in dense focus assays. Recently Sriniva-
san et al. (1997) showed that an N-terminal T-antigen
fragment containing amino acids 1–136 could not com-
plement a mutant with a small deletion in the T/t common
region.
Which activities in each of the cooperating regions are
sufficient for immortalization remains to be determined.
The results of Conzen and Cole (1995) suggest that Rb
binding is needed for immortalization. However, this re-
sult has not been found consistently. We showed previ-
ously (Thompson et al., 1990) that cell lines are readily
derived from colonies expressing mutant T-antigens from
which the Rb-binding region is removed. Similarly, Chen
and Paucha (1990) reported the consistent generation of
cell lines from colonies of primary cells transfected with
plasmids encoding Rb-deficient T-antigens. In both of
these cases, primary B6MEF were utilized. Also, Zalvide
and DeCaprio (1995) showed that the Rb-binding domain
of T-antigen was not needed for immortalization of
mouse embryo fibroblasts. The reasons for the differ-
ences in the results are not clear, but could relate to the
number of times the primary cultures were passaged
prior to use, the passage protocols, or the specific mu-
tants used. Additional studies will be needed to distin-
guish among these possibilities.
In addition to the capacity to extend the life span of
cells, large T-antigen contains a number of duplicated
activities in separable regions of the protein. Both an
N-terminal and nonoverlapping C-terminal T-antigen
segments independently bind topoisomerase and the
cellular DNA polymerase a (Dornreiter et al., 1990; Sim-
mons et al., 1996). Nonoverlapping regions within the
N-terminus of large T-antigen bind the TATA-box protein,
TBP (Johnson et al., 1996). Similarly, nonoverlapping seg-
ments of T-antigen cooperate with an activated ras on-
cogene (Cavender et al., 1995).
The ras oncogene has been shown to induce prema-
ture senescence in primary cells (Serrano et al., 1997).
Only cells that have escaped senescence can be trans-
formed efficiently by an activated ras oncogene (New-
bold and Overell, 1983, reviewed in Barbacid, 1987).
Thus, ras cooperation can be used to identify activities in
oncoproteins that are involved in escape from senes-
cence. Previously we (Cavender et al., 1995) examined
regions of T-antigen for the ability to cooperate with an
activated ras oncogene in forming dense colonies on
primary cell monolayers. We showed that T1-147 and
T251-708 independently cooperated with ras as effi-
ciently as did full-length T-antigen. We showed further
that immortalizing capacity as measured by the ability to
cooperate with ras and as measured by escape from
senescence in the absence of a cooperating oncogene
are distinguishable genetically. The results presented
herein confirm the distinction between immortalization
and ras cooperation by showing that the T1-147 and
T251-708 proteins will not independently immortalize
B6MEF.
The finding that fragments of T-antigen that are insuf-
ficient to immortalize cells independently cooperate with
ras suggests one of two possibilities. There may be
independent pathways to senescence operating, one
that predominates during induction of premature senes-
cence by expression of the ras oncogene and a second
that predominates during natural senescence. Different
T-antigen activities may be needed to overcome each
pathway. Alternatively, but not mutually exclusively, the
ras oncogene may contain one or more activities that
participate in immortalization.
How the activities in the two T-antigen segments im-
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pact extending the life span of B6MEF and how the
functions that promote extended cell division relate to
those that act in ras cooperation remain to be deter-
mined by combined loss-of-function and retention-of-
function analyses.
MATERIALS AND METHODS
Plasmids
The plasmids pPVU0 (Kalderon and Smith, 1984),
pdl2005 (Sleigh et al., 1978), T147NS (Sompayrac and
Danna, 1989), CAV251-708 and CAV251-708NL (Cavender
et al., 1995), and pdl536 (Sompayrac and Danna, 1983)
have been described previously. They encode, respec-
tively, full-length large T-antigen (T1-708) and small t-
antigen, T1-708 alone, and an N-terminal fragment of
T-antigen containing amino acids 1–147 (T1-147), a C-
terminal T-antigen fragment containing amino acids 251–
708 (T251-708), or T251-708 containing the T-antigen
nuclear localization signal inserted immediately before
amino acid 251. The plasmid pT146sac-dl is a modifica-
tion of pT147NS. The plasmid pT147NS contains the
entire large T-antigen coding region. Expression of the
T1-147 protein depends on a single stop codon immedi-
ately following codon 147. To limit the possibility of se-
lecting reversions of the mutation during immortalization
assays, we removed the early region nucleotides be-
tween codon 148 and the polyadenylation site. To do so,
oligonucleotide-directed insertional mutagenesis was
used to insert SacI restriction nuclease recognition sites
in place of nucleotides 4373 to 4367 and in place of
nucleotides 2643 to 2648 by use of procedures de-
scribed in detail previously (Cavender et al., 1995; Kier-
stead and Tevethia, 1993). The resulting plasmid was
treated with SacI and the large cleavage fragment was
purified from an agarose gel after electrophoresis by
using the procedure exactly as described previously
(Kierstead and Tevethia, 1993). The fragment then was
ligated to produce pT147Sac-dl. As a result of the dele-
tion, only seven nucleotides remain between the stop
codon at position 148 and the polyadenylation signal. In
the event that a mutational conversion of the stop codon
to an amino acid-specifying codon occurred in B6MEF
transfected with pT147sac-dl, the N-terminal T-antigen
fragment would be extended no more than three amino
acids.
Immortalization assay
Transfection of B6MEF was performed as described
previously (Kierstead and Tevethia, 1993). Basically, pri-
mary mouse embryo fibroblasts derived from 14- to 16-
day-old C57BL/6 mouse embryos were prepared as de-
scribed (Tevethia, 1984) and seeded into 75-cm2 flasks at
a density of 4 3 105 cells per flask in 20 ml Dulbecco’s
modified minimal medium supplemented with 100 mg
streptomycin/ml, 100 mg kanamycin/ml, 100 U penicillin/
ml, 0.03% glutamine, 0.07% NaHCO3, and 10% fetal bo-
vine serum (DMEM–10%FBS). On the following day, DNA-
–calcium phosphate precipitates, each containing 10 mg
salmon sperm DNA and 1 mg of T-antigen-expression
plasmid/ml, were prepared as described previously (Te-
vethia, 1984). Then 1 ml of precipitate was added directly
to the medium in each of two flasks of B6MEF. After
overnight incubation at 37°C, the medium containing the
precipitate was replaced with fresh DMEM–10%FBS.
Thereafter, the medium in the flasks was changed twice
a week until colonies appeared in 3 to 4 weeks. The
colonies in each flask were counted. Next, colonies were
picked from each flask by the use of cloning pipettes and
were expanded. Three stages of expansion into cell lines
were monitored (Fig. 1). First, individual colonies were
transferred to 4.5-cm2 wells of 12-well plates. When con-
fluent monolayers formed in the wells (stage 1) the cells
were removed by trypsin treatment and transferred to a
25-cm2 flask. When the cells in a flask divided sufficiently
to form a monolayer (stage 2), they were removed by
trypsin treatment, and 1
10
of the resulting cell suspension
was transferred to a new flask containing DMEM–
10%FBS. Each time a confluent monolayer formed in the
flask, the culture was passaged 1:10 for at least 10
consecutive passages. Cells that withstood this passage
schedule were said to have escaped senescence and,
therefore, to constitute an immortal cell line.
Detection of the senescence-associated b-
galactosidase
The endogenous SA-b-gal was detected essentially as
described (Dimri et al., 1995). Specifically, cells were
recovered from liquid nitrogen storage at passage 1 and
were passed 1:2 each time they formed a cell monolayer.
At each cell passage, 5 3 104 cells were seeded into a
60-mm dish containing DMEM–10%FBS supplemented
with 0.21% NaHCO3. Forty-eight hours later the cells
were fixed and examined for the senescence-associated
endogenous b-galactosidase by staining for activity at
pH 6.0. Specifically, the medium was removed and the
cells were washed twice with phosphate-buffered saline
(PBS). The cells were fixed by exposure to PBS contain-
ing 2% formaldehyde and 0.2% gluteraldehyde for 2.5
min. The fixative was removed and the cells were
washed twice with PBS. Then 2.5 ml staining solution
containing 1 mg/ml X-gal, 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 150 mM NaCl, 2 mM MgCl2 in 40 mM citric
acid–sodium phosphate buffer, pH 6.0, were added to the
dish. After overnight incubation at 37°C, the cultures
were examined for the presence of blue cells.
Immunoprecipitation
Expression of wild-type and mutant T-antigen seg-
ments in clonally derived cell lines was monitored by
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immunoprecipitation. Cells were labeled with [35S]methi-
onine for 1 h, following which protein extracts were
prepared as described previously (Kierstead and Te-
vethia, 1993). The T-antigens were immunoprecipitated
by using the monoclonal antibodies PAb902, which rec-
ognizes an epitope between amino acids 1 and 82
(Thompson et al., 1990), PAb416, which recognizes an
epitope between amino acids 82 and 127 (Sawai et al.,
1994; Tevethia et al., 1997b), and PAb901, which recog-
nizes an epitope between amino acids 684 and 698
(Kierstead and Tevethia, 1993). As a control, protein ex-
tracts were treated with the monoclonal antibody gD,
which recognizes an epitope in the herpes simplex virus
gD glycoprotein (Jennings et al., 1987; Johnson and
Spear, 1982). Immunoprecipitated proteins were sub-
jected to SDS–10% PAGE and were detected by autora-
diography.
Immunofluorescence assay
In order to determine the subcellular location of mu-
tant T-antigens, DNA constructs encoding T251-708 or
T251-708NL were transiently transfected into the African
green monkey kidney cell line TC7 (Robb and Heubner,
1973) by using the DEAED–chloroquin procedure as de-
scribed previously (Cavender et al., 1995) with the fol-
lowing exceptions. Cells were seeded into 60-mm dishes
containing sterile coverslips. After overnight incubation
at 37°C, the cells were transfected with 1 mg of the
appropriate plasmid DNA. Forty-eight hours later, the
cells on the coverslips were fixed and stained by using a
cocktail of PAb901 and PAb902 antibodies exactly as
described (Thompson et al., 1990).
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